HER2/Neu Over-expressing Locally Advanced Breast Cancer Clinical Trials

HER2/Neu Over-expressing Locally Advanced Breast Cancer

Explore clinical trials studying HER2/Neu Over-expressing Locally Advanced Breast Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

HER2/Neu Over-expressing Locally Advanced Breast Cancer trial results

Completed

Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer

NCT01007942

Conditions: Breast Diseases, Breast Neoplasms, HER2/Neu Over-expressing Locally Advanced Breast Cancer, +5 more
Locations: University of Arizona / Cancer Center AZ Onc Assoc Tucson, Arizona, United States

University of Arizona / Cancer Center Deptof Uof A/Arizona Cancer(3) Tucson, Arizona, United States

University of California San Diego - Moores Cancer Center La Jolla - UCSD Moores Cancer La Jolla, California, United States

Rocky Mountain Cancer Centers RMCC Greenwood Village, Colorado, United States

View all 161 locations

View Trial Details

Related conditions